Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GP130 receptor agonist-1

🥰Excellent
Catalog No. T9157Cas No. 339303-87-6
Alias N-(4-Fluorophenyl)-4-phenyl-2-thiazolami

GP130 receptor agonist-1 (N-(4-Fluorophenyl)-4-phenyl-2-thiazolami) is a potent, brain-penetrant and orally active GP130 receptor agonist.

GP130 receptor agonist-1

GP130 receptor agonist-1

🥰Excellent
Purity: 99.62%
Catalog No. T9157Alias N-(4-Fluorophenyl)-4-phenyl-2-thiazolamiCas No. 339303-87-6
GP130 receptor agonist-1 (N-(4-Fluorophenyl)-4-phenyl-2-thiazolami) is a potent, brain-penetrant and orally active GP130 receptor agonist.
Pack SizePriceAvailabilityQuantity
5 mg$41In Stock
10 mg$65In Stock
25 mg$128In Stock
50 mg$238In Stock
100 mg$345In Stock
200 mg$470In Stock
1 mL x 10 mM (in DMSO)$58In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "GP130 receptor agonist-1"

Select Batch
Purity:99.62%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GP130 receptor agonist-1 (N-(4-Fluorophenyl)-4-phenyl-2-thiazolami) is a potent, brain-penetrant and orally active GP130 receptor agonist.
In vitro
Compound 2 (N-(4-Fluorophenyl)-4-phenyl-2-thiazolami) treatment showed a 2-fold increase in phosphorylation of STAT3 within 10 min at its regulatory Tyr705 site in SH-SY5Y cells.. Compound 2 treatment increases phosphorylation of AKT at its regulatory Thr308 site and phosphorylation of ERK1/2 at its regulatory Thr202/Tyr204 site in the serum free media condition in SH-SY5Y cells, and in primary cortical neurons.
In vivo
For Compound 2 (N-(4-Fluorophenyl)-4-phenyl-2-thiazolami), mice are dosed orally at 10 or 30 mg/kg, or injected subcutaneously (SQ) at 10 mg/kg, and euthanized after 1, 2, 4, 6, and 8 h post dose. At 2 h after SQ delivery at 10 mg/kg the brain Cmax is 161 ng/g while dosing at 30 mg/kg orally, results in the brain Cmax of 156 ng/g (0.57 μM). The brain to plasma ratio for 2 is ~4:1 for oral 30 mg/kg and ~7.5:1 for 10 mg/kg SQ injection.
AliasN-(4-Fluorophenyl)-4-phenyl-2-thiazolami
Chemical Properties
Molecular Weight270.32
FormulaC15H11FN2S
Cas No.339303-87-6
SmilesFC1=CC=C(NC2=NC(=CS2)C2=CC=CC=C2)C=C1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/ml (203.46 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.6993 mL18.4966 mL36.9932 mL184.9660 mL
5 mM0.7399 mL3.6993 mL7.3986 mL36.9932 mL
10 mM0.3699 mL1.8497 mL3.6993 mL18.4966 mL
20 mM0.1850 mL0.9248 mL1.8497 mL9.2483 mL
50 mM0.0740 mL0.3699 mL0.7399 mL3.6993 mL
100 mM0.0370 mL0.1850 mL0.3699 mL1.8497 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GP130 receptor agonist-1 | purchase GP130 receptor agonist-1 | GP130 receptor agonist-1 cost | order GP130 receptor agonist-1 | GP130 receptor agonist-1 chemical structure | GP130 receptor agonist-1 in vivo | GP130 receptor agonist-1 in vitro | GP130 receptor agonist-1 formula | GP130 receptor agonist-1 molecular weight